Join
Live feed
·
INSIDERFilingvia Quantisnow
Centessa Pharmaceuticals plc logo

President, Orexin Program Accardi Mario Alberto sold $174,846 worth of Ordinary Shares (8,172 units at $21.40), decreasing direct ownership by 4% to 197,394 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNTA (Centessa Pharmaceuticals plc) and more on Quantisnow.